Proteus debuts digital cancer drug

Proteus Digital Health said today that the first cancer patients were treated using its digital oncology therapy, which combines oral chemotherapy with an ingestible sensor.
Patients with stage 3 and 4 colorectal cancer at the University of Minnesota Health and Fairview Health Services were treated with digital capecitabine. The Redwood City, Calif.-based company plans to use its sensor-drug combination to record and share data such as the time and dose of chemotherapy that a patient ingests.
Get the full story at our sister site, Drug Delivery Business News.
The post Proteus debuts digital cancer drug appeared first on MassDevice.

Source: Mass Device - January 17, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Featured mHealth (Mobile Health) Oncology Pharmaceuticals Proteus Digital Health Source Type: news